Streetbeat News

Equity Actions

LUNG

Pulmonx Corporation will present at the Canaccord Genuity 43rd Annual Growth Conference. This could potentially influence the company's stock (LUNG).

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:15 pm

ORLY

O'Reilly Automotive's CEO, Greg Johnson, is set to retire. Brad Beckham will take over as CEO, and Brent Kirby will become President.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 9:15 pm

PTEN

Patterson-UTI Energy has reduced its capital expenditure forecast for the second half of 2023 to $485 million.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:08 pm

FTI

TechnipFMC has announced an additional $400 million buyback program. This move is expected to return value to shareholders and reflects the company's confidence in its financial position.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:07 pm

BIOL

Biolase has announced a 1-for-100 reverse stock split. This action is typically taken by companies to increase the market price of their shares and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 9:01 pm

TNET

TriNet has announced an increase in its stock repurchase program by $1B, bringing the total to $1.4B.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 8:51 pm

ENVX

Enovix Corporation has established a research and design center in India. This move is expected to expand the company's global footprint and enhance its research and development capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 8:50 pm

NARI

Inari Medical will be presenting at the 43rd Annual Canaccord Growth Conference.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 8:49 pm

HUM

A significant bearish stance has been taken on Humana (NYSE:HUM) by a large investor, as observed in the options history. The overall sentiment of these big-money traders is split between 35% bullish and 64% bearish. Whales have been targeting a price range from $410.0 to $490.0 for Humana over the last 3 months. The price of HUM is down -1.35% at $448.21. Several financial institutions have given their ratings and price targets for Humana.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 8:47 pm

AAWH

Ascend Wellness Holdings, Inc. (OTC:AAWH) CFO, Dan Neville, highlighted the capital shortage in the cannabis industry during the Benzinga Cannabis Capital Conference. He noted that the situation is severe for both public and private multi-state operators (MSOs) in the capital-intensive industry. Neville predicts that the capital shortage will continue to fuel consolidation in the industry. Despite these challenges, Ascend Holdings plans to focus on smaller bolt-on M&A, with Maryland being a successful example of this strategy.

Portfolio Pulse from Joana Scopel

July 26, 2023 | 8:44 pm